Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Avadel Pharmaceuticals PLC as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −2 vs. Q2 2023
- Shares held
- 54.4M
- +2.42M (+4.7%) vs. Q2 2023
- Total value
- $559.4M
- −$296.8M (−34.7%) vs. Q2 2023
- New holders
- 14
- 35 more added
- Sold out
- 16
- 26 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVDL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $16 |
| Q1 2026 | 2 | $442 |
| Q4 2025 | 208 | $1.60B |
| Q3 2025 | 188 | $1.22B |
| Q2 2025 | 174 | $721.2M |
| Q1 2025 | 177 | $613.0M |
| Q4 2024 | 160 | $837.4M |
| Q3 2024 | 176 | $979.2M |
| Q2 2024 | 156 | $1.04B |
| Q1 2024 | 126 | $1.18B |
| Q4 2023 | 113 | $795.3M |
| Q3 2023 | 99 | $559.4M |
| Q2 2023 | 101 | $856.2M |
| Q1 2023 | 93 | $443.2M |
| Q4 2022 | 83 | $239.5M |
| Q3 2022 | 76 | $157.2M |
| Q2 2022 | 82 | $82.3M |
| Q1 2022 | 81 | $244.5M |
| Q4 2021 | 85 | $287.0M |
| Q3 2021 | 82 | $314.2M |
| Q2 2021 | 80 | $219.1M |
| Q1 2021 | 77 | $294.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Avadel Pharmaceuticals PLC; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Portolan Capital Management, LLC | 0 | $0 | 0.00% | −289,906−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −130,473−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −127,293−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −124,500−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Investors Asset Management of Georgia Inc | 0 | $0 | 0.00% | −93,975−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −66,000−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −14,214−100.0% | Sold out |
| QP Wealth Management, LLC | 0 | $0 | 0.00% | −13,380−100.0% | Sold out |
| Pinebridge Investments, L.P. | 0 | $0 | 0.00% | −2,478−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −626−100.0% | Sold out |